Selected research
Industry Research
Tiopronin Powder Injection Industry Research Report 2026
Market perspective
The global Tiopronin Powder Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Tiopronin Powder Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Tiopronin Powder Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Tiopronin Powder Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Tiopronin Powder Injection include AdvaCare Pharma, Cycle Pharma, Mission Pharmacal, Hainan Quanxing Pharmaceuticals, Hangzhou Zhongmei Huadong Pharmaceutical, Ma'anshan Fengyuan Pharmaceutical, Shandong Sino Pharmaceutical Technology, Shanxi Zhendong Taisheng Pharmaceutical and Shenyang Xinma Pharmaceutica, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Tiopronin Powder Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Tiopronin Powder Injection Market by Company
AdvaCare Pharma
Cycle Pharma
Mission Pharmacal
Hainan Quanxing Pharmaceuticals
Hangzhou Zhongmei Huadong Pharmaceutical
Ma'anshan Fengyuan Pharmaceutical
Shandong Sino Pharmaceutical Technology
Shanxi Zhendong Taisheng Pharmaceutical
Shenyang Xinma Pharmaceutica
Wuhan Hiteck Biological Pharma
Yuanda Pharmaceutical
Yuekang Pharmaceutical
Tiopronin Powder Injection Segment by Type
0.1g per Bottle
0.2g per Bottle
Tiopronin Powder Injection Segment by Application
Fatty Liver
Drug-induced Liver Injury
Alcoholic Fatty Liver
Hepatitis
Other
Tiopronin Powder Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tiopronin Powder Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tiopronin Powder Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tiopronin Powder Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Tiopronin Powder Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Tiopronin Powder Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Tiopronin Powder Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.1g per Bottle
- 0.2g per Bottle
Applications
- Fatty Liver
- Drug-induced Liver Injury
- Alcoholic Fatty Liver
- Hepatitis
- Other
Companies covered
- AdvaCare Pharma
- Cycle Pharma
- Mission Pharmacal
- Hainan Quanxing Pharmaceuticals
- Hangzhou Zhongmei Huadong Pharmaceutical
- Ma'anshan Fengyuan Pharmaceutical
- Shandong Sino Pharmaceutical Technology
- Shanxi Zhendong Taisheng Pharmaceutical
- Shenyang Xinma Pharmaceutica
- Wuhan Hiteck Biological Pharma
- Yuanda Pharmaceutical
- Yuekang Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Tiopronin Powder Injection Market Size (2021-2032)
- 2.2.2 Global Tiopronin Powder Injection Sales (2021-2032)
- 2.2.3 Global Tiopronin Powder Injection Market Average Price (2021-2032)
- 2.3 Tiopronin Powder Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 0.1g per Bottle
- 2.3.3 0.2g per Bottle
- 2.4 Tiopronin Powder Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Fatty Liver
- 2.4.3 Drug-induced Liver Injury
- 2.4.4 Alcoholic Fatty Liver
- 2.4.5 Hepatitis
- 2.4.6 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Tiopronin Powder Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Tiopronin Powder Injection Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Tiopronin Powder Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Tiopronin Powder Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Tiopronin Powder Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Tiopronin Powder Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Tiopronin Powder Injection, Product Type & Application
- 3.8 Global Manufacturers of Tiopronin Powder Injection, Established Date
- 3.9 Global Tiopronin Powder Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 AdvaCare Pharma
- 4.1.1 AdvaCare Pharma Company Information
- 4.1.2 AdvaCare Pharma Business Overview
- 4.1.3 AdvaCare Pharma Tiopronin Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 AdvaCare Pharma Tiopronin Powder Injection Product Portfolio
- 4.1.5 AdvaCare Pharma Recent Developments
- 4.2 Cycle Pharma
- 4.2.1 Cycle Pharma Company Information
- 4.2.2 Cycle Pharma Business Overview
- 4.2.3 Cycle Pharma Tiopronin Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Cycle Pharma Tiopronin Powder Injection Product Portfolio
- 4.2.5 Cycle Pharma Recent Developments
- 4.3 Mission Pharmacal
- 4.3.1 Mission Pharmacal Company Information
- 4.3.2 Mission Pharmacal Business Overview
- 4.3.3 Mission Pharmacal Tiopronin Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mission Pharmacal Tiopronin Powder Injection Product Portfolio
- 4.3.5 Mission Pharmacal Recent Developments
- 4.4 Hainan Quanxing Pharmaceuticals
- 4.4.1 Hainan Quanxing Pharmaceuticals Company Information
- 4.4.2 Hainan Quanxing Pharmaceuticals Business Overview
- 4.4.3 Hainan Quanxing Pharmaceuticals Tiopronin Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hainan Quanxing Pharmaceuticals Tiopronin Powder Injection Product Portfolio
- 4.4.5 Hainan Quanxing Pharmaceuticals Recent Developments
- 4.5 Hangzhou Zhongmei Huadong Pharmaceutical
- 4.5.1 Hangzhou Zhongmei Huadong Pharmaceutical Company Information
- 4.5.2 Hangzhou Zhongmei Huadong Pharmaceutical Business Overview
- 4.5.3 Hangzhou Zhongmei Huadong Pharmaceutical Tiopronin Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hangzhou Zhongmei Huadong Pharmaceutical Tiopronin Powder Injection Product Portfolio
- 4.5.5 Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments
- 4.6 Ma'anshan Fengyuan Pharmaceutical
- 4.6.1 Ma'anshan Fengyuan Pharmaceutical Company Information
- 4.6.2 Ma'anshan Fengyuan Pharmaceutical Business Overview
- 4.6.3 Ma'anshan Fengyuan Pharmaceutical Tiopronin Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Ma'anshan Fengyuan Pharmaceutical Tiopronin Powder Injection Product Portfolio
- 4.6.5 Ma'anshan Fengyuan Pharmaceutical Recent Developments
- 4.7 Shandong Sino Pharmaceutical Technology
- 4.7.1 Shandong Sino Pharmaceutical Technology Company Information
- 4.7.2 Shandong Sino Pharmaceutical Technology Business Overview
- 4.7.3 Shandong Sino Pharmaceutical Technology Tiopronin Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Shandong Sino Pharmaceutical Technology Tiopronin Powder Injection Product Portfolio
- 4.7.5 Shandong Sino Pharmaceutical Technology Recent Developments
- 4.8 Shanxi Zhendong Taisheng Pharmaceutical
- 4.8.1 Shanxi Zhendong Taisheng Pharmaceutical Company Information
- 4.8.2 Shanxi Zhendong Taisheng Pharmaceutical Business Overview
- 4.8.3 Shanxi Zhendong Taisheng Pharmaceutical Tiopronin Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Shanxi Zhendong Taisheng Pharmaceutical Tiopronin Powder Injection Product Portfolio
- 4.8.5 Shanxi Zhendong Taisheng Pharmaceutical Recent Developments
- 4.9 Shenyang Xinma Pharmaceutica
- 4.9.1 Shenyang Xinma Pharmaceutica Company Information
- 4.9.2 Shenyang Xinma Pharmaceutica Business Overview
- 4.9.3 Shenyang Xinma Pharmaceutica Tiopronin Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Shenyang Xinma Pharmaceutica Tiopronin Powder Injection Product Portfolio
- 4.9.5 Shenyang Xinma Pharmaceutica Recent Developments
- 4.10 Wuhan Hiteck Biological Pharma
- 4.10.1 Wuhan Hiteck Biological Pharma Company Information
- 4.10.2 Wuhan Hiteck Biological Pharma Business Overview
- 4.10.3 Wuhan Hiteck Biological Pharma Tiopronin Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Wuhan Hiteck Biological Pharma Tiopronin Powder Injection Product Portfolio
- 4.10.5 Wuhan Hiteck Biological Pharma Recent Developments
- 4.11 Yuanda Pharmaceutical
- 4.11.1 Yuanda Pharmaceutical Company Information
- 4.11.2 Yuanda Pharmaceutical Business Overview
- 4.11.3 Yuanda Pharmaceutical Tiopronin Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Yuanda Pharmaceutical Tiopronin Powder Injection Product Portfolio
- 4.11.5 Yuanda Pharmaceutical Recent Developments
- 4.12 Yuekang Pharmaceutical
- 4.12.1 Yuekang Pharmaceutical Company Information
- 4.12.2 Yuekang Pharmaceutical Business Overview
- 4.12.3 Yuekang Pharmaceutical Tiopronin Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Yuekang Pharmaceutical Tiopronin Powder Injection Product Portfolio
- 4.12.5 Yuekang Pharmaceutical Recent Developments
5 Global Tiopronin Powder Injection Market Scenario by Region
- 5.1 Global Tiopronin Powder Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Tiopronin Powder Injection Sales by Region: 2021-2032
- 5.2.1 Global Tiopronin Powder Injection Sales by Region: 2021-2026
- 5.2.2 Global Tiopronin Powder Injection Sales by Region: 2027-2032
- 5.3 Global Tiopronin Powder Injection Revenue by Region: 2021-2032
- 5.3.1 Global Tiopronin Powder Injection Revenue by Region: 2021-2026
- 5.3.2 Global Tiopronin Powder Injection Revenue by Region: 2027-2032
- 5.4 North America Tiopronin Powder Injection Market Facts & Figures by Country
- 5.4.1 North America Tiopronin Powder Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Tiopronin Powder Injection Sales by Country (2021-2032)
- 5.4.3 North America Tiopronin Powder Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Tiopronin Powder Injection Market Facts & Figures by Country
- 5.5.1 Europe Tiopronin Powder Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Tiopronin Powder Injection Sales by Country (2021-2032)
- 5.5.3 Europe Tiopronin Powder Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Tiopronin Powder Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Tiopronin Powder Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Tiopronin Powder Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Tiopronin Powder Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Tiopronin Powder Injection Market Facts & Figures by Country
- 5.7.1 South America Tiopronin Powder Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Tiopronin Powder Injection Sales by Country (2021-2032)
- 5.7.3 South America Tiopronin Powder Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Tiopronin Powder Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Tiopronin Powder Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Tiopronin Powder Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Tiopronin Powder Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Tiopronin Powder Injection Sales by Type (2021-2032)
- 6.1.1 Global Tiopronin Powder Injection Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Tiopronin Powder Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Tiopronin Powder Injection Revenue by Type (2021-2032)
- 6.2.1 Global Tiopronin Powder Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Tiopronin Powder Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Tiopronin Powder Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Tiopronin Powder Injection Sales by Application (2021-2032)
- 7.1.1 Global Tiopronin Powder Injection Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Tiopronin Powder Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Tiopronin Powder Injection Revenue by Application (2021-2032)
- 7.2.1 Global Tiopronin Powder Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Tiopronin Powder Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Tiopronin Powder Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Tiopronin Powder Injection Value Chain Analysis
- 8.1.1 Tiopronin Powder Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Tiopronin Powder Injection Production Mode & Process
- 8.2 Tiopronin Powder Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Tiopronin Powder Injection Distributors
- 8.2.3 Tiopronin Powder Injection Customers
9 Global Tiopronin Powder Injection Analyzing Market Dynamics
- 9.1 Tiopronin Powder Injection Industry Trends
- 9.2 Tiopronin Powder Injection Industry Drivers
- 9.3 Tiopronin Powder Injection Industry Opportunities and Challenges
- 9.4 Tiopronin Powder Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst